FISCHER35.20

Fischer Medical Ventures Limited

· Pharma & Health
₹ CrorePeersTARSONSLAXMIDENTLFABTECHGKBMcap ₹2,304 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY26
31/03/2026
Last 12M
30/06/2026
Returns
Return on Common Equity8.058.05
Return on Assets4.624.62
Return on Capital Employed9.719.71
Return on Invested Capital6.047.07
Margins
EBITDA Margin13.9613.64
Operating Margin13.0013.00
Pretax Margin15.1012.02
Net Income Margin10.058.12
FCF Margin-33.24-33.24
Additional
Effective Tax Rate32.9432.21
Dvd Payout Ratio0.88
Sustainable Growth Rate7.988.05
Incremental Operating Margin %10.95
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.